Skip to content

Study · Non-randomized trial · n = 8 · 1987

2 results

Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.

Fuessl HS, Carolan G, Williams G, Bloom SR

Digestion1 Jan 1987Cited by 63 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In healthy volunteers, octreotide reduced gastric half-emptying time from 37.2 +/- 3.3 to 23.3 +/- 3.4 min versus control (p less than 0.01).

    In plain wordsIn healthy volunteers, octreotide accelerated stomach emptying compared with the control study.

    Peptide
    Octreotide
    Outcome
    DecreaseGastric half-emptying time
    Study

    n = 8

    Comparator
    Control study
    Outcome group
    Gastrointestinal motility · Gastrointestinal
    Studied dose
    50 micrograms once · subcutaneousAs given in this study (human).

    Measurements

    Time to 50% isotope disappearance
    37.2 min
    control study; +/- 3.3 (dispersion type not stated)
    Time to 50% isotope disappearance
    23.3 min
    after SMS injection; +/- 3.4 (dispersion type not stated)
    p value
    < 0.01 not applicable
    control versus after SMS injection

    Source sentences

    Summary
    Gastric emptying was accelerated, with a significant reduction of the time taken to 50% isotope disappearance (37.2 +/- 3.3 min during control study vs 23.3 +/- 3.4 min after SMS injection; p less than 0.01).
    1 context sentence
    Summary · context
    The effect on gut motility of a single subcutaneous injection of 50 micrograms of the long-acting somatostatin analogue, SMS 201-995, was investigated in 8 normal volunteers who took a drink containing 99mTc and lactulose with a mixed meal.
  2. 02HumanNon-randomized trialEfficacy outcome

    In healthy volunteers, octreotide prolonged mouth-to-caecum transit from 57.3 +/- 9.4 to 203.6 +/- 14.7 min versus control (p less than 0.001).

    In plain wordsIn healthy volunteers, octreotide increased gut transit time compared with the control study.

    Peptide
    Octreotide
    Outcome
    IncreaseMouth-to-caecum transit time
    Study

    n = 8

    Comparator
    Control study
    Outcome group
    Gastrointestinal motility · Gastrointestinal
    Studied dose
    50 micrograms once · subcutaneousAs given in this study (human).

    Measurements

    Mouth-to-caecum transit time
    57.3 min
    control; +/- 9.4 (dispersion type not stated)
    Mouth-to-caecum transit time
    203.6 min
    after SMS; +/- 14.7 (dispersion type not stated)
    p value
    < 0.001 not applicable
    control versus after SMS

    Source sentences

    Summary
    In contrast, MCTT was prolonged from 57.3 +/- 9.4 min (control) to 203.6 +/- 14.7 min after SMS (p less than 0.001).
    1 context sentence
    Summary · context
    The effect on gut motility of a single subcutaneous injection of 50 micrograms of the long-acting somatostatin analogue, SMS 201-995, was investigated in 8 normal volunteers who took a drink containing 99mTc and lactulose with a mixed meal.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.